NATCO is one of the biggest brands behind the creation of the survival medicines for Hepatitis C treatment. Living to the core purpose of “Making speciality medicines accessible to all”, it has been working on launching the generic brand of HEPCINAT (Sofosbuvir), the HEPCINAT-LP (Ledipasvir/Sofosbuvir) and NATDAC (Daclatasvir).
In fact, it is among one of the first companies that has launched the generic versions of Sofusbuvir (SOF) and also the combination medicines of the same in India. Not only does it treat Hepatitis C virus (HCV) and patient’s affected by it but also provides affordable prices for such treatment. The main aim of this brand is to eradicate HCV in India in due course of time.
Hepcinat LP- The Tablet
Hepcinat LP has been the most popular and the most recommended medicine for Hepatitis C treatment. It is generally sold under the Indian brand Hepcinat Lp. The major active ingredient of the tablet is Ledipasvir and Sofosbuvir. The package contains 28 tablets of 400 mg. Mainly the expiry ranges from 1-2 years and comes in a safe plastic bottle packaging for higher intactness.
Recommended Dosage
- Hepcinat-LP tablets must only be administered under the prohibited supervision of only and only a Hepatologist.
- It is recommended for adults over the age of 18 years, only.
- Oral intake with water once per day is recommended.
- The duration of the treatment may vary from a period of 8 weeks to 24 weeks.
- Stopping the intake of any other anti-viral medications along with Hepcinat until and unless instructed by the consultant is not recommended.
Benefits of Hepcinat-LP Tablets
- Being a rich formulation of the combination of anti-viral medications, such as- Ledipasvir and Sofosbuvir, it is used for treatment of Chronic Hepatitis C Virus (CHCV) infection of genotype 1.
- It is a 100% prescription medicine that contains Ledipasvir (90mg) - a viral NS5A inhibitor and Sofosbuvir (400mg) - a nucleotide inhibitor against the viral RNA polymerase.
- It provides an effective treatment for Hepatitis C Genotype 1 with a record cure rate of around 94% to 99%.
- It also acts against multiplication of the Hepatitis C Virus infection and weakens the virus and inhibits its further reproduction and imitation.
